Neurofibroma: Difference between revisions
Sara Mohsin (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) |
||
Line 29: | Line 29: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Neurofibroma staging| | [[Neurofibroma staging|Diagnostic criteria]] | [[Neurofibroma history and symptoms|History and Symptoms]] | [[Neurofibroma physical examination|Physical Examination]] | [[Neurofibroma laboratory findings|Laboratory Findings]] | [[Neurofibroma x ray|X Ray]] | [[Neurofibroma CT|CT]] | [[Neurofibroma MRI|MRI]] | [[Neurofibroma ultrasound|Ultrasound]] | [[Neurofibroma other imaging findings|Other Imaging Findings]] | [[Neurofibroma other diagnostic studies|Other Diagnostic Studies]] | [[Neurofibroma biopsy|Biopsy]] | ||
==Treatment== | ==Treatment== |
Revision as of 17:37, 29 March 2019
Neurofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neurofibroma On the Web |
American Roentgen Ray Society Images of Neurofibroma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Kiran Singh, M.D. [3] Shanshan Cen, M.D. [4]
Synonyms and keywords: Endoneural fibroma, Myxofibroma of nerve sheath, Neurofibromyxoma, Perineural fibroblastoma, Perineural fibroma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neurofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy
Treatment
Medical therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies